Mitochondria and Cancer

Dr. Farzad Taghizadeh-Hesary is an Assistant Professor of Radiation Oncology at Iran University of Medical Sciences, specializing in oncology, radiobiology, and cancer metabolism. He earned his M.D. in 2015 from IUMS and completed a Radiation Oncology residency at Shahid Beheshti University of Medical Sciences, ranking among the top graduates nationally. His thesis examined late toxicities after IMRT for nasopharyngeal carcinoma, reflecting a commitment to precision radiotherapy.His expertise spans clinical and academic oncology, with a focus on tumor microenvironment and mitochondrial metabolism in cancer. He has published more than 80 peer-reviewed articles and serves on editorial boards including BMC Cancer and PLoS ONE. Awards include the Razi Medical Science Research Prize and the Outstanding Reviewer Award from JCO Clinical Cancer Informatics; Publons Academy ranked him the top global Radiation Oncology reviewer in 2021.His research centers on personalized radiotherapy, cancer immunotherapy, and metabolic interventions targeting mitochondrial dysfunction, advancing translational oncologySumel Ashique has been working as an assistant professor at Bengal College of Pharmaceutical Sciences & Research, Durgapur West Bengal, India, West Bengal, India. He has several years of teaching experience. He has achieved 70+ publications of International and national accredited reputed journals . He has knowledge in drug delivery, nanotechnology and targeted treatment strategy. He has also 6 granted patents from IP and Australia & dozens of book chapters have been submitted to well-known publishers. Dr. Babak Behnam has completed his PhD degree at the University College London (UCL) in Human Genetics. Then he served as postdoctoral research fellow at the University of Michigan School of Medicine and University of Central Florida (UCF). He joined the Undiagnosed Disease Program (UDP) at NIH while doing an American Board of Medical Genetics and Genomic in clinical biochemical laboratory genetics at NHGRI, NIH. He joined NSF International as a clinical research organization. Dr. Behnam has published more than 70 peer-reviewed papers and has nine patents to his name throughout his career; also, has served as an Editorial Board Member of several scientific journals. He has enthusiasm in translational research, neuroscience & neurogenetics, and biochemical & molecular mechanisms utilizing advanced technological improvements in biochemical genetics, genomics, and NGS platforms. Also, he has an experience and interest in clinical research, and regulatory and scientific analysis of clinical trials.Dr. Vliora Maria is a Molecular Biologist with extensive background in molecular biology and integrative physiology. She has previously studied mutations of immunoglobulins in Chronic Lymphocytic Leukemia patients, and ALK mutations and downstream signaling in Neuroblastoma. Dr. Vliora has a PhD in Biomedical Research from University of Thessaly, Greece and University of Brescia, Italy. She has worked on the development of biocompatible/biodegradable bioscaffolds for targeting adipose tissue as well as on potential nanomedical treatments for brain tumors as well as blood malignancies. Her research work is now focusing on environmental influences that can affect human health and on the use of novel biodegradable bio-scaffolds for allografting adipose stem cells in humans. She collaborated with reputable organizations (WHO, ILO) on projects aiming to enhance human health and wellbeing. She now works as a Project Manager on EU funded projects.

• 1. Mitochondria: Origin, Structure, and Function2. Mitochondrial Metabolism and Trafficking in Cancer3. Mitochondrial Genome and Cancer4. Mitochondrial-nuclear Crosstalk and Its Role in Cancer5. Mitochondria and Tumor Microenvironment6. Mitochondria and Cancer Stem Cells7. Mitochondria, Exosome, Cancer8. Mitochondria, Microbiota, Cancer9. MiRNAs and Their Impacts on Cancer Cell’s Mitochondria10. Mitochondria and Cancer Prevention11. Mitochondria and Cancer Diagnosis12. Mitochondrial Metabolism as a Prognostic Biomarker (Mitochondria and Cancer Progression)13. Mitochondria, Tumor Microenvironment, and Radioresistance14. Mitochondria and Resistance to Chemotherapy15. Mitochondria and Resistance to Targeted Therapies16. Mitochondria and Resistance to Immunotherapy17. Mitochondria Enhancing Strategies in Cancer18. Advances in Targeted Anti-mitochondrial Therapies19. Applying Magnetic Fields to Target Mitochondria20. what the Artificial Intelligence (AI) Proposes for the Mitochondria Role in Cancer